EX-99.1 2 ea029838101ex99-1.htm PRESS RELEASE, DATED JULY 17, 2026 Exhibit 99.1 SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026 Company’s advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event FORT LAUDERDALE, Fla. - July 17, 2026 - via IBN - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the advanced SSi Mantra surgical robotic system (the “SSi Mantra”) will be showcased at the 2026 Society of Robotic Surgery Annual Meeting (“SRS 2026”) in Hollywood, Florida, on July 23 - 26, 2026. The SSi Mantra will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the event. The livestreamed robotic telesurgery, a partial nephrectomy, will be performed remotely by Dr. Amitabh Singh from SS Innovations’ headquarters in Gurugram, India, on a patient at Rajeev Gandhi…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
SS Innovations International Inc.
SSIINASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On July 17, 2026, SSi issued a press release announcing that the Company’s advanced SSi Mantra surgical robotic system will be showcased at the 2026 Society of Robotic Surgery Annual Meeting in Hollywood, Florida on July 23 - 26, 2026. A copy of the press release is included as Exhibit 99.1 to this Current Report.
Company context
We are a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “SSi Mantra”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries. While surgical robotic systems have gained acceptance globally in the past two decades for providing greater efficiency, better clinical outcomes and reducing healthcare costs, access to such systems remains largely limited to developed countries such as the United States (the “U.S.”), the European Union (the “EU”) and Japan. With the SSi Mantra, we are breaking down barriers and accelerating access to surgical robotics technologies in underserved regions of the world.